Clinical Trial: GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923396) titled 'GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis' on Nov. 02.

Brief Summary: This study is a single-arm, open-label clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of GK01 cell therapy in patients with gastric cancer and peritoneal metastasis.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Gastric Cancer (GC)

Intervention: DRUG: GK01 combination with nab-paclitaxel and S-1

Intraperitoneal infusion of GK01 is planned after the second cycle of nab-paclitaxel plus S-1 (tegafur) chemotherapy (C2D21).At 6 weeks after the GK01 cell infusion, participants will c...